Latest News for: viridian

Edit

Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid ...

The Milton Standard Journal 22 Dec 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Dec 22, 2025-- ....
Edit

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire 05 Dec 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq.
Edit

Viridian Therapeutics, Inc.: Initiation of Research Coverage (William Blair & Company LLC)

Public Technologies 03 Dec 2025
William Blair initiated research coverage of Viridian Therapeutics, Inc ... Viridian's lead asset veligrotug is an anti-IGF-1R monoclonal antibody in development for the treatment of thyroid eye disease (TED).
Edit

Viridian

The Indiana Times 02 Dec 2025
View on PetFinder ... .
Edit

Viridian Metals Announces Closing of First Tranche of Financing and Short Form Vertical Amalgamation

Nasdaq Globe Newswire 02 Dec 2025
Viridian Metals announces the closing of first tranche of financing and short form vertical amalgamation ... .
Edit

Viridian Solar offers new solutions to integrate PV systems with roof windows

PV Magazine 20 Nov 2025
Viridian Solar, a UK-based roof-integrated solar PV specialist, announced new flashing products to seamlessly integrate its solar panels with skylight-style windows made by Keylite Roof Windows ... Viridian Solar was founded in 2007.
Edit

Third Quarter 2025 Financial Statement (Viridian Therapeutics Inc)

Public Technologies 08 Nov 2025
). The text version of this document is not available ... Viridian Therapeutics Inc.
Edit

Third Quarter 2025 Press Release (Viridian Therapeutics Inc)

Public Technologies 08 Nov 2025
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress ... WALTHAM, Mass.--(BUSINESS WIRE)-- Viridian Therapeutics, Inc ... Viridian will pay DRI tiered royalties on annual U.S ... About Viridian Therapeutics.
Edit

Viridian Metals Launches Financing to Build on Positive Market Momentum

Canada Newswire 07 Nov 2025
7, 2025 /CNW/ - Viridian Metals Inc. (CSE. VRDN) ("Viridian" or the "Company") is pleased to announce a non-brokered private placement (the "Private Placement") consisting of the issuance of a combination of ... About Viridian Metals.
Edit

Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

The Eagle-Tribune 05 Nov 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Nov 5, 2025-- ... .
Edit

Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress (Form 8-K) (Viridian Therapeutics Inc)

Public Technologies 05 Nov 2025
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress ... - November 5, 2025 - Viridian Therapeutics, Inc ... Viridian will pay DRI tiered royalties on annual U.S ... About Viridian Therapeutics.
Edit

Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q) (Viridian Therapeutics Inc)

Public Technologies 05 Nov 2025
) MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS ... Actual results and the timing of events could differ materially from those discussed in these forward-looking statements ... Revenue ... Viridian Therapeutics Inc ... (noodl.
Edit

Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for ...

Hastings Tribune 03 Nov 2025
WALTHAM, Mass.--(BUSINESS WIRE)--Nov 3, 2025-- ... .
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Viridian Therapeutics Inc)

Public Technologies 27 Oct 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... Washington, D.C ... OMB Number. 3235-0287 ... 0.5 ... 2 ... Viridian Therapeutics, Inc.\DE [VRDN] 5 ... Viridian Therapeutics Inc.
Edit

Material Agreement (Form 8-K) (Viridian Therapeutics Inc)

Public Technologies 23 Oct 2025
) Item 1.01. Entry into a Material Definitive Agreement. On October 21, 2025, Viridian Therapeutics, Inc ... The securities described above were offered pursuant to a shelf registration statement (File No ... Disclaimer. Viridian Therapeutics Inc ... (noodl.

Article Search

tools
×
×
×
×